Background: Microinvasive carcinoma represents a subgroup of cervical cancer that is characterized by having a good prognosis and a conservative treatment possibilities such as the LEEP. Objective: To determine clinical characteristics, diagnosis, management and follow - up of patients diagnosed with microinvasive carcinoma of the cervix in Oncology Hospital Solca Quito-Ecuador. Methodology: This case series report describes the clinical characteristics, diagnosis, management and follow-up of patients with microinvasive cervical cancer. We included a review of 28 patients records with a diagnosis of microinvasive carcinoma type IA1 according to FIGO classification between 2005-2017in an Oncology Hospital of Ecuador. Clinical data, cytology results and LEEP of all included patients were reviewed and analyzed and HPV was determined in 15 patients who attended follow-up. Results: Patients age ranged from 21 to 80 years, sexual activity initiation at 17,8 years old ,average of sexual partners 2, 20% of the patients included were smokers. All patients included had a diagnosis of microinvasive carcinoma (IA1 according to FIGO classification) and underwent conservative therapy with LEEP. A follow-up of 15 patients, between 6 and 12 months after treatment, HPV test was negative in 94.9% (14 patients) and only 1 patient had a positive result (6.66%), which corresponded to subtype 16, Finally cytology was also performed on 15 patients, of whom only one patient had CIN II. Conclusions: Conservative management (with LEEP) in patients with stage IA1 microinvasive carcinoma of the cervix represents the best treatment option due to the low recurrence of the disease.